Related Experiment Videos
[Changes in CSF tryptophan metabolite levels in infantile spasms]
H Yamamoto1, B Egawa, K Horiguchi
1Department of Pediatrics, St. Marianna University School of Medicine, Kanagawa.
No to Hattatsu = Brain and Development
|November 1, 1992
Summary
Infantile spasms (IS) in infants show altered cerebrospinal fluid (CSF) tryptophan metabolites, with lower serotonin and higher kynurenine. Treatment with adrenocorticotropic hormone (ACTH) normalized these levels, suggesting a link between seizures and neurotransmitter imbalance.
Area of Science:
- Neurochemistry
- Pediatric Neurology
- Metabolomics
Context:
- Infantile spasms (IS) are a severe epilepsy syndrome in infants.
- Tryptophan metabolism pathways are crucial for neurotransmitter synthesis.
- Previous research has not fully elucidated the role of CSF metabolites in IS.
Purpose:
- To investigate cerebrospinal fluid (CSF) tryptophan metabolite concentrations in infants with asymptomatic infantile spasms (IS).
- To compare metabolite levels before and after treatment with adrenocorticotropic hormone (ACTH).
- To explore the relationship between IS, neurotransmitter activity, and ACTH treatment efficacy.
Summary:
- CSF analysis revealed significantly lower levels of serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), and kynurenine (KYN) in IS patients compared to controls.
- Conversely, 3-hydroxykynurenine (3-OHKY) levels were significantly higher in IS patients before treatment.
- Following successful ACTH treatment, 5-HIAA levels increased, while KYN and 3-OHKY levels decreased, indicating a normalization of tryptophan metabolism.
Impact:
- Findings suggest a significant decrease in serotonergic activity or altered kynurenine pathway turnover in infants with IS.
- The study highlights the potential role of tryptophan metabolite alterations in the pathophysiology of IS.
- ACTH treatment may exert its therapeutic effect by modulating these neurochemical pathways, offering insights into novel therapeutic targets.